ABT three-lens brief
Evidence-based stock research on ABT. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 27.1pp over 30 days. · Trading at 0% of its 52-week range — deep in the lower band.
- Trading at 0% of its 52-week range — deep in the lower band.
- RSI at 27 — technically oversold.
- Underperforming SPY by 27.1pp over 30 days.
- Analyst mean target $118.64 — 34% above current (25 analysts).
- Debt-to-equity of 64.8 — balance-sheet-heavy.
ABT closed at $88.77 (-0.77%) as of 2026-05-04. Market cap: $154.62B. P/E (trailing) 24.9. Positives: analyst mean target $118.64 — 34% above current (25 analysts).. Concerns: trading at 0% of its 52-week range — deep in the lower band.; rSI at 27 — technically oversold.. Last quarter: Revenue $11.16B, net income $1.08B, free cash flow $6.34B.
Why three lenses on ABT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ABTacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ABT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ABT brief"></iframe>